• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Walgreens to Purchase Pharmacy Files of 185 Fred’s Pharmacies Across Southeastern U.S.

Share:

September 16, 2018

Walgreens and Fred’s, Inc. today announced they have entered into a definitive asset purchase agreement, pursuant to which Walgreens will acquire pharmacy patient prescription files and related pharmacy inventory of 185 Fred’s stores located across 10 Southeastern states.

Under the agreement, the aggregate consideration to be paid by Walgreens to Fred’s is $165M, subject to adjustment, plus an amount equal to the value of related pharmacy inventory.

“This agreement increases patient access to Walgreens pharmacies in the Southeastern U.S., and allows us to introduce more people to Walgreens trusted pharmacy services in these communities. We look forward to welcoming Fred’s patients and team members who are hired into available Walgreens positions,” said Richard Ashworth, Walgreens President of Operations.

The transaction is part of a previously announced plan by Fred’s to unlock shareholder value by monetizing non-core assets through strategic transactions. Fred’s will continue to operate its retail stores at most of these locations after the pharmacies close. Once the transaction is complete, Fred’s will continue to operate approximately 162 pharmacies across nearly 600 stores. Fred’s pharmacy staff at the closing locations will have an opportunity to apply for any available positions at Walgreens.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“With this agreement, we have taken a major step towards achieving one of our main goals of eliminating our debt balance,” said Joe Anto, Interim CEO and CFO of Fred’s. “We look forward to partnering with Walgreens to transition our pharmacy patients in these locations as smoothly as possible.”

The transaction is subject to the expiration or termination of applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the satisfaction or waiver of certain other customary closing conditions. The companies expect the file transfers to begin in the fourth quarter of calendar 2018 and be completed in the first quarter of calendar 2019.

Patients whose prescriptions are being transferred will be notified by letter, and the parties will work together to help ensure a smooth transition. Once patient prescriptions are transferred from Fred’s to Walgreens, patients will have access to Walgreens trusted pharmacy services across a network of approximately 9,800 pharmacies nationwide.

PJ SOLOMON is acting as financial advisor and Akin Gump Strauss Hauer & Feld LLP is acting as legal advisor to Fred’s. Sidley Austin LLP and Weil Gotshal & Manges LLP are acting as legal advisors to Walgreens.

Date: September 17, 2018

Source: BusinessWire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Relay Medical Closes Acquisition of IoT Cybersecurity Firm, Cybeats Technologies Inc.Relay Medical Closes Acquisition of IoT Cybersecurity Firm, Cybeats Technologies Inc.
  • Moody’s: Amgen, Biogen, Gilead have ‘high capacity’ to do M&AMoody’s: Amgen, Biogen, Gilead have ‘high capacity’ to do M&A
  • Why Medical Devices Require a Modern UIWhy Medical Devices Require a Modern UI
  • Microsoft Launches $40M, 5-Year AI for Health Initiative to Advance Health GloballyMicrosoft Launches $40M, 5-Year AI for Health Initiative to Advance Health Globally
  • General Catalyst’s HATCO Plans to Purchase Ohio Healthcare System Summa HealthGeneral Catalyst’s HATCO Plans to Purchase Ohio Healthcare System Summa Health
  • 7wireVentures Launches $217M Growth & Opportunity Fund to Support Later-Stage Digital Health Investments7wireVentures Launches $217M Growth & Opportunity Fund to Support Later-Stage Digital Health Investments
  • Celling Biosciences, a pioneer in cellular therapy, acquires rights to ThermiGenCelling Biosciences, a pioneer in cellular therapy, acquires rights to ThermiGen
  • Amazon’s Alexa Now Helps Users Find COVID-19 VaccinesAmazon’s Alexa Now Helps Users Find COVID-19 Vaccines

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications